Compumed Stock Analysis
| CMPD Stock | USD 3.02 0.25 7.65% |
CompuMed is overvalued with Real Value of 2.77 and Hype Value of 3.02. The main objective of CompuMed pink sheet analysis is to determine its intrinsic value, which is an estimate of what CompuMed is worth, separate from its market price. There are two main types of CompuMed's stock analysis: fundamental analysis and technical analysis.
The CompuMed pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and CompuMed's ongoing operational relationships across important fundamental and technical indicators.
CompuMed |
CompuMed Pink Sheet Analysis Notes
The company recorded a loss per share of 0.01. CompuMed had not issued any dividends in recent years. The entity had 1:25 split on the 23rd of May 2022. CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California. Compumed operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 8 people.The quote for CompuMed is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on CompuMed please contact Lee Keddie at 310 258 5000 or go to https://www.compumed.net.CompuMed Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. CompuMed's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding CompuMed or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| CompuMed generated a negative expected return over the last 90 days | |
| CompuMed has high historical volatility and very poor performance |
CompuMed Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CompuMed's market, we take the total number of its shares issued and multiply it by CompuMed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.CompuMed Profitablity
The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.08) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.08.Technical Drivers
As of the 26th of December, CompuMed shows the Risk Adjusted Performance of 0.0029, mean deviation of 4.19, and Standard Deviation of 6.45. CompuMed technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CompuMed standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and kurtosis to decide if CompuMed is priced correctly, providing market reflects its regular price of 3.02 per share. Given that CompuMed has information ratio of (0.02), we suggest you to validate CompuMed's prevailing market performance to make sure the company can sustain itself at a future point.CompuMed Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.
CompuMed Outstanding Bonds
CompuMed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CompuMed uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CompuMed bonds can be classified according to their maturity, which is the date when CompuMed has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
CompuMed Predictive Daily Indicators
CompuMed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CompuMed pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
CompuMed Forecast Models
CompuMed's time-series forecasting models are one of many CompuMed's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CompuMed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About CompuMed Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how CompuMed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CompuMed shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as CompuMed. By using and applying CompuMed Pink Sheet analysis, traders can create a robust methodology for identifying CompuMed entry and exit points for their positions.
CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California. Compumed operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 8 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding CompuMed to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Complementary Tools for CompuMed Pink Sheet analysis
When running CompuMed's price analysis, check to measure CompuMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuMed is operating at the current time. Most of CompuMed's value examination focuses on studying past and present price action to predict the probability of CompuMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuMed's price. Additionally, you may evaluate how the addition of CompuMed to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |